FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011787625> ?p ?o ?g. }

• W2011787625 endingPage "733" @default.
• W2011787625 startingPage "728" @default.
• W2011787625 abstract "Toxic epidermal necrolysis is an extremely severe drug reaction, manifesting itself by widespread apoptosis of keratinocytes, generally considered to result from Fas/CD95-FasLigand interaction, but of unknown primary mechanism. We looked at the role of cells present in the skin blisters as probable effectors of this immune reaction. In a patient suffering from cotrimoxazole-induced toxic epidermal necrolysis, blister fluid cells were phenotyped by FACS and tested without prior restimulation for cytotoxicity on autologous and allogeneic cells in the presence of the drug. Blister fluid lymphocytes were predominantly CD8+, DR+, CLA+, CD56+ T lymphocytes, perforin positive and expressing preferentially two Vbeta chains of the T cell receptor repertoire. These lymphocytes were cytotoxic only in the presence of the drug towards autologous EBV transformed lymphocytes and towards allogeneic cells sharing HLA-Cw4. Cytotoxicity occurred in the presence of either cotrimoxazole, sulfamethoxazole, or the nitroso metabolite of sulfamethoxazole, but not with the hydroxylamine metabolite of sulfamethoxazole. The lysis was blocked by an anti-MHC class I monoclonal antibody. It was abolished by EGTA and CMA, but neither by anti-fas, brefeldin A, nor by anti-TRAIL receptor monoclonal antibodies, strongly suggesting perforin/granzyme-mediated cytotoxicity, without implication of Fas or TRAIL at this stage. This is direct evidence that T lymphocytes present within the lesions of toxic epidermal necrolysis may exhibit, without any re-stimulation, a drug-specific cytotoxicity against autologous cells. Harboring the markers of classical CTL and MHC class I restriction these lymphocytes reacted against the parent drug and one of its reactive metabolites. These results challenge several current concepts and could support new therapeutic approaches." @default.
• W2011787625 created "2016-06-24" @default.
• W2011787625 creator A5004423617 @default.
• W2011787625 creator A5012521997 @default.
• W2011787625 creator A5029144785 @default.
• W2011787625 creator A5040153913 @default.
• W2011787625 creator A5040446667 @default.
• W2011787625 creator A5061495123 @default.
• W2011787625 creator A5074838373 @default.
• W2011787625 creator A5076334985 @default.
• W2011787625 date "2002-04-01" @default.
• W2011787625 modified "2023-10-18" @default.
• W2011787625 title "Drug Specific Cytotoxic T-Cells in the Skin Lesions of a Patient with Toxic Epidermal Necrolysis" @default.
• W2011787625 cites W1594345612 @default.
• W2011787625 cites W1939108455 @default.
• W2011787625 cites W1983504482 @default.
• W2011787625 cites W1995968109 @default.
• W2011787625 cites W2000386027 @default.
• W2011787625 cites W2018558067 @default.
• W2011787625 cites W2021918026 @default.
• W2011787625 cites W2025805650 @default.
• W2011787625 cites W2036425689 @default.
• W2011787625 cites W2038226782 @default.
• W2011787625 cites W2079780398 @default.
• W2011787625 cites W2089708688 @default.
• W2011787625 cites W2092814615 @default.
• W2011787625 cites W2126627307 @default.
• W2011787625 cites W2164740372 @default.
• W2011787625 cites W2317624504 @default.
• W2011787625 cites W2321102680 @default.
• W2011787625 cites W3116890861 @default.
• W2011787625 cites W4321508824 @default.
• W2011787625 doi "https://doi.org/10.1046/j.1523-1747.2002.01622.x" @default.
• W2011787625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11918724" @default.
• W2011787625 hasPublicationYear "2002" @default.
• W2011787625 type Work @default.
• W2011787625 sameAs 2011787625 @default.
• W2011787625 citedByCount "264" @default.
• W2011787625 countsByYear W20117876252012 @default.
• W2011787625 countsByYear W20117876252013 @default.
• W2011787625 countsByYear W20117876252014 @default.
• W2011787625 countsByYear W20117876252015 @default.
• W2011787625 countsByYear W20117876252016 @default.
• W2011787625 countsByYear W20117876252017 @default.
• W2011787625 countsByYear W20117876252018 @default.
• W2011787625 countsByYear W20117876252019 @default.
• W2011787625 countsByYear W20117876252020 @default.
• W2011787625 countsByYear W20117876252021 @default.
• W2011787625 countsByYear W20117876252022 @default.
• W2011787625 countsByYear W20117876252023 @default.
• W2011787625 crossrefType "journal-article" @default.
• W2011787625 hasAuthorship W2011787625A5004423617 @default.
• W2011787625 hasAuthorship W2011787625A5012521997 @default.
• W2011787625 hasAuthorship W2011787625A5029144785 @default.
• W2011787625 hasAuthorship W2011787625A5040153913 @default.
• W2011787625 hasAuthorship W2011787625A5040446667 @default.
• W2011787625 hasAuthorship W2011787625A5061495123 @default.
• W2011787625 hasAuthorship W2011787625A5074838373 @default.
• W2011787625 hasAuthorship W2011787625A5076334985 @default.
• W2011787625 hasBestOaLocation W20117876251 @default.
• W2011787625 hasConcept C109316439 @default.
• W2011787625 hasConcept C147483822 @default.
• W2011787625 hasConcept C154317977 @default.
• W2011787625 hasConcept C16005928 @default.
• W2011787625 hasConcept C167672396 @default.
• W2011787625 hasConcept C185592680 @default.
• W2011787625 hasConcept C202751555 @default.
• W2011787625 hasConcept C203014093 @default.
• W2011787625 hasConcept C2776062744 @default.
• W2011787625 hasConcept C2780664588 @default.
• W2011787625 hasConcept C55493867 @default.
• W2011787625 hasConcept C71924100 @default.
• W2011787625 hasConcept C86803240 @default.
• W2011787625 hasConceptScore W2011787625C109316439 @default.
• W2011787625 hasConceptScore W2011787625C147483822 @default.
• W2011787625 hasConceptScore W2011787625C154317977 @default.
• W2011787625 hasConceptScore W2011787625C16005928 @default.
• W2011787625 hasConceptScore W2011787625C167672396 @default.
• W2011787625 hasConceptScore W2011787625C185592680 @default.
• W2011787625 hasConceptScore W2011787625C202751555 @default.
• W2011787625 hasConceptScore W2011787625C203014093 @default.
• W2011787625 hasConceptScore W2011787625C2776062744 @default.
• W2011787625 hasConceptScore W2011787625C2780664588 @default.
• W2011787625 hasConceptScore W2011787625C55493867 @default.
• W2011787625 hasConceptScore W2011787625C71924100 @default.
• W2011787625 hasConceptScore W2011787625C86803240 @default.
• W2011787625 hasIssue "4" @default.
• W2011787625 hasLocation W20117876251 @default.
• W2011787625 hasLocation W20117876252 @default.
• W2011787625 hasOpenAccess W2011787625 @default.
• W2011787625 hasPrimaryLocation W20117876251 @default.
• W2011787625 hasRelatedWork W1542886054 @default.
• W2011787625 hasRelatedWork W1601672058 @default.
• W2011787625 hasRelatedWork W1680389360 @default.
• W2011787625 hasRelatedWork W2020086511 @default.
• W2011787625 hasRelatedWork W2041811834 @default.
• W2011787625 hasRelatedWork W2058581379 @default.
• W2011787625 hasRelatedWork W2061842245 @default.

• next